Aquestive(AQST) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update Warren, N.J., August 11, 2025 – Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced financial results for the second quarter ended June 30, 2025, and provided a strategic business update. "The second quarter mar ...